<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Atopic Dermatitis <-> Type 2 Diabetes Mellitus - Comorbidity</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        a {
            color: var(--primary-dark);
            text-decoration: none;
        }

        a:hover {
            text-decoration: underline;
        }

        .internal-link {
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
        }

        .internal-link:hover {
            text-decoration-thickness: 2px;
        }

        .dismech-inline-link {
            margin-left: 6px;
            font-size: 0.78rem;
            font-weight: 600;
            color: #0369a1;
            text-decoration: underline;
            text-underline-offset: 2px;
            text-decoration-thickness: 1px;
            white-space: nowrap;
        }

        .dismech-inline-link:hover {
            text-decoration-thickness: 2px;
        }

        .curation-gap-badge {
            display: inline-flex;
            align-items: center;
            margin-left: 8px;
            padding: 2px 8px;
            border-radius: 999px;
            font-size: 0.72rem;
            font-weight: 700;
            letter-spacing: 0.01em;
            text-transform: uppercase;
            background: #fef2f2;
            border: 1px solid #fecaca;
            color: #b91c1c;
            vertical-align: middle;
        }

        .missing-ontology-link {
            color: #b91c1c !important;
            text-decoration: underline dotted;
            text-underline-offset: 2px;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.1rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .header-subtitle {
            margin-top: 12px;
            color: rgba(255,255,255,0.85);
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
            font-weight: 700;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-accent {
            background: #ede9fe;
            color: #5b21b6;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-weight: 600;
            margin-bottom: 4px;
        }

        .mapping-notes {
            font-size: 0.9rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .field {
            margin-top: 6px;
        }

        .field-label {
            font-weight: 600;
            margin-right: 6px;
        }

        .metrics {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 10px;
            margin-top: 8px;
        }

        .metric {
            background: var(--bg);
            border: 1px solid var(--border);
            border-radius: 10px;
            padding: 8px 10px;
            font-size: 0.9rem;
        }

        .evidence {
            margin-top: 8px;
        }

        .evidence-item {
            border-left: 3px solid #94a3b8;
            padding-left: 10px;
            margin: 8px 0;
            color: var(--text-muted);
        }

        .evidence-item strong {
            color: var(--text);
        }

        .go-terms {
            margin: 8px 0 0;
            padding-left: 18px;
        }

        details {
            margin-top: 12px;
        }

        pre {
            background: #0f172a;
            color: #e2e8f0;
            padding: 12px;
            border-radius: 10px;
            overflow-x: auto;
            font-size: 0.85rem;
        }

        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        @media (max-width: 720px) {
            .page-header {
                padding: 28px 20px;
            }

            .page-header h1 {
                font-size: 1.7rem;
            }

            .section-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Comorbidity</span>
        </nav>

        <header class="page-header">
            <h1>Atopic Dermatitis <-> Type 2 Diabetes Mellitus</h1>
            <div class="header-meta">
                <span class="badge badge-category">Comorbidity</span>
                
                <span class="badge badge-mondo">A_BEFORE_B</span>
                
                
                <span class="badge badge-category">CANDIDATE</span>
                
            </div>
            
            <div class="header-subtitle">Non-obvious comorbidity with mixed epidemiologic evidence. Recent cohort and Mendelian randomization studies suggest AD increases T2D risk, while systematic review results are sensitive to T2D definition.</div>
            
        </header>

        <div class="section-grid">
            <div class="card">
                <div class="card-header">
                    <div class="card-icon" style="background: #e0f2fe; color: #0369a1;">A</div>
                    <h2 class="card-title">Disease A</h2>
                </div>
                <div class="mapping-title">
                    
                    <a class="internal-link" href="../disorders/Atopic_Dermatitis.html">Atopic Dermatitis</a>
                    
                </div>
                
                <div class="field"><span class="field-label">Slug:</span>Atopic_Dermatitis</div>
                
                
                
            </div>
            <div class="card">
                <div class="card-header">
                    <div class="card-icon" style="background: #ede9fe; color: #6d28d9;">B</div>
                    <h2 class="card-title">Disease B</h2>
                </div>
                <div class="mapping-title">
                    
                    <a class="internal-link" href="../disorders/Type_2_Diabetes_Mellitus.html">Type 2 Diabetes Mellitus</a>
                    
                </div>
                
                <div class="field"><span class="field-label">Slug:</span>Type_2_Diabetes_Mellitus</div>
                
                
                
            </div>
        </div>

        
        <div class="card" id="causal-graphs">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">G</div>
                <h2 class="card-title">Causal Mechanism Graphs</h2>
            </div>
            
            <h3>Atopic Dermatitis</h3>
            <div class="mermaid-container">
                <pre class="mermaid">graph LR
    Epidermal_Barrier_Dysfunction[&#34;Epidermal Barrier Dysfunction&#34;]
    Pruritogen_Induced_Neuronal_Activation[&#34;Pruritogen-Induced Neuronal Activation&#34;]
    Scratching_Induced_Barrier_Injury[&#34;Scratching-Induced Barrier Injury&#34;]
    Secondary_Inflammatory_Amplification[&#34;Secondary Inflammatory Amplification&#34;]
    Type_2_Immune_Response[&#34;Type 2 Immune Response&#34;]

    Type_2_Immune_Response --&gt; Epidermal_Barrier_Dysfunction
    Type_2_Immune_Response --&gt; Pruritogen_Induced_Neuronal_Activation
    Pruritogen_Induced_Neuronal_Activation --&gt; Scratching_Induced_Barrier_Injury
    Scratching_Induced_Barrier_Injury --&gt; Secondary_Inflammatory_Amplification

    style Epidermal_Barrier_Dysfunction fill:#dbeafe
    style Pruritogen_Induced_Neuronal_Activation fill:#dbeafe
    style Scratching_Induced_Barrier_Injury fill:#dbeafe
    style Secondary_Inflammatory_Amplification fill:#dbeafe
    style Type_2_Immune_Response fill:#dbeafe</pre>
            </div>
            
            
        </div>
        

        
        <div class="card" id="signals">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">S</div>
                <h2 class="card-title">Association Signals</h2>
            </div>
            <div class="mapping-section">
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 1</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">EHR_COHORT_ASSOCIATION</span>
                        <span class="tag tag-mechanistic">A_BEFORE_B</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>Korean NHIS-NSC 2.0 cohort (2002-2015), adults with AD vs matched controls.</div>
                    
                    
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>HR</strong>: 1.44</div>
                            
                            <div>CI: 1.27 - 1.63</div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Adjusted hazard ratio for incident T2D in adult AD patients.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/37595846" target="_blank">PMID:37595846</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"The risk of T2DM in the adult AD group was significantly higher than in the control group (adjusted hazard ratio 1.44, 95% confidence interval 1.27-1.63, P &lt; 0.001)."</div>
            
            
            <div>Cohort analysis reports higher T2D risk among adults with AD.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 2</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">COMPUTATIONAL_INFERENCE</span>
                        <span class="tag tag-mechanistic">A_BEFORE_B</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>GWAS summary statistics (MR analysis of AD and T2D).</div>
                    
                    
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>OR</strong>: 1.07</div>
                            
                            <div>CI: 1.02 - 1.11</div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Mendelian randomization estimate for AD on T2D.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/37322504" target="_blank">PMID:37322504</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: COMPUTATIONAL</div>
            
            
            <div>"Genetically predicted AD led to a higher risk of T2D (OR, 1.07; 95% CI, 1.02, 1.11; P = 0.003)."</div>
            
            
            <div>MR suggests a causal AD -&gt; T2D effect.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 3</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">LITERATURE_ASSOCIATION</span>
                        <span class="tag tag-mechanistic">UNKNOWN</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>Systematic review and meta-analysis in adults with AD.</div>
                    
                    
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>OR</strong>: 1.11</div>
                            
                            <div>CI: 0.87 - 1.42</div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Pooled OR for unspecified but suspected T2D; not significant.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/29210061" target="_blank">PMID:29210061</a></strong>
                
                 (REFUTE)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"No association was observed between AD and unspecified but suspected type 2 diabetes [pooled odds ratio (OR) 1·11, 95% confidence interval (CI) 0·87-1·42]."</div>
            
            
            <div>Meta-analysis reports no association for unspecified/suspected T2D definitions.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
                <div class="mapping-item">
                    <div class="mapping-title">Signal 4</div>
                    <div class="tag-list" style="margin-bottom: 8px;">
                        <span class="tag tag-parent">LITERATURE</span>
                        <span class="tag tag-classification">LITERATURE_ASSOCIATION</span>
                        <span class="tag tag-mechanistic">UNKNOWN</span>
                    </div>
                    <div class="field"><span class="field-label">Population:</span>Systematic review and meta-analysis in adults with AD (explicitly defined T2D).</div>
                    
                    
                    
                    
                    <div class="field"><span class="field-label">Temporal:</span>
                        A before B: 
                        , B before A: 
                        , Same time: 
                    </div>
                    

                    
                    
                    <div class="metrics">
                        
                        <div class="metric">
                            <div><strong>OR</strong>: 1.37</div>
                            
                            <div>CI: 1.17 - 1.61</div>
                            
                            <div>p: </div>
                            <div>FDR: </div>
                            <div>Pooled OR when T2D is explicitly defined.</div>
                        </div>
                        
                    </div>
                    

                    
                    
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/29210061" target="_blank">PMID:29210061</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"However, AD was associated with type 2 diabetes when explicitly defined, with a pooled OR of 1·37 (95% CI 1·17-1·61)."</div>
            
            
            <div>Meta-analysis reports a positive association for explicitly defined T2D.</div>
            
        </div>
        
    </div>
    
    
                    
                    

                    
                </div>
                
            </div>
        </div>
        

        
        <div class="card" id="hypotheses">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #1e40af;">H</div>
                <h2 class="card-title">Hypotheses</h2>
            </div>
            
            <div class="mapping-item">
                <div class="field">Hypothesis: chronic inflammatory activity in AD may increase systemic metabolic risk and contribute to insulin resistance and T2D.</div>
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/31690388" target="_blank">PMID:31690388</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods."</div>
            
            
            <div>AD is described as a chronic inflammatory dermatosis, supporting an inflammation-based hypothesis.</div>
            
        </div>
        
    </div>
    
    
                
                <div class="field"><span class="field-label">Pathophysiology:</span></div>
                
                <div class="field">
                    <strong>Systemic inflammatory burden</strong>: Chronic inflammatory signaling in AD could promote metabolic stress and insulin resistance that increase T2D risk.
                </div>
                
                
                <div class="field">
                    <span class="field-label">Biological processes:</span>
                    <div class="tag-list">
                        
                        
                        <span class="tag tag-classification">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank">inflammatory response</a>
    
    
    
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/GO_0042092" target="_blank">type 2 immune response</a>
    
    
    
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/GO_0019221" target="_blank">cytokine-mediated signaling pathway</a>
    
    
    
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/GO_0070670" target="_blank">response to interleukin-4</a>
    
    
    
                        </span>
                        
                        
                        
                        <span class="tag tag-classification">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/GO_0035962" target="_blank">response to interleukin-13</a>
    
    
    
                        </span>
                        
                        
                    </div>
                </div>
                
                
                <div class="field">
                    <span class="field-label">Gene products:</span>
                    <div class="tag-list">
                        
                        
                        <span class="tag tag-mechanistic">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/NCIT_C20508" target="_blank">Interleukin-4</a>
    
    
    
                        </span>
                        
                        
                        
                        <span class="tag tag-mechanistic">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/NCIT_C20515" target="_blank">Interleukin-13</a>
    
    
    
                        </span>
                        
                        
                        
                        <span class="tag tag-mechanistic">
                            
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/NCIT_C113837" target="_blank">Interleukin-31</a>
    
    
    
                        </span>
                        
                        
                    </div>
                </div>
                
                
                
    
    <div class="evidence">
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/31690388" target="_blank">PMID:31690388</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods."</div>
            
            
            <div>AD is explicitly described as inflammatory, motivating systemic inflammation as a shared mechanism.</div>
            
        </div>
        
        <div class="evidence-item">
            <div>
                
                <strong><a href="http://www.ncbi.nlm.nih.gov/pubmed/31690388" target="_blank">PMID:31690388</a></strong>
                
                 (SUPPORT)
            </div>
            
            <div>Source: HUMAN_CLINICAL</div>
            
            
            <div>"In acute lesions of AD, the T-helper type 2 cells produce interleukin (IL) 4, IL-13, and IL-31, which may potentiate barrier dysfunction and contribute to pruritus."</div>
            
            
            <div>AD lesions show Th2 cytokine production, supporting a type 2 immune response mechanism.</div>
            
        </div>
        
    </div>
    
    
                
                
                
            </div>
            
        </div>
        

        

        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #fce7f3; color: #9d174d;">P</div>
                <h2 class="card-title">Shared Phenotypes</h2>
            </div>
            <ul class="go-terms">
                
                <li>
                    
                    
    
    
    
    
    <a href="http://purl.obolibrary.org/obo/HP_0000989" target="_blank">Pruritus</a>
    
    
    
                    
                </li>
                
            </ul>
        </div>
        

        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e2e8f0; color: #334155;">Y</div>
                <h2 class="card-title">Raw YAML</h2>
            </div>
            <details>
                <summary>Show YAML</summary>
                <pre>name: com_Atopic_Dermatitis__Type_2_Diabetes_Mellitus
creation_date: &#39;2026-02-02T02:02:16Z&#39;
updated_date: &#39;2026-02-02T03:53:46Z&#39;
curation_status: CANDIDATE
notes: &gt;-
  Non-obvious comorbidity with mixed epidemiologic evidence. Recent cohort and
  Mendelian randomization studies suggest AD increases T2D risk, while systematic
  review results are sensitive to T2D definition.

disease_a:
  slug: Atopic_Dermatitis

disease_b:
  slug: Type_2_Diabetes_Mellitus

directionality: A_BEFORE_B

hypotheses:
- description: &gt;-
    Hypothesis: chronic inflammatory activity in AD may increase systemic
    metabolic risk and contribute to insulin resistance and T2D.
  evidence:
  - reference: PMID:31690388
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods.&#34;
    explanation: AD is described as a chronic inflammatory dermatosis, supporting an inflammation-based hypothesis.
  pathophysiology:
  - name: Systemic inflammatory burden
    description: &gt;-
      Chronic inflammatory signaling in AD could promote metabolic stress and
      insulin resistance that increase T2D risk.
    biological_processes:
    - preferred_term: inflammatory response
      term:
        id: GO:0006954
        label: inflammatory response
    - preferred_term: type 2 immune response
      term:
        id: GO:0042092
        label: type 2 immune response
    - preferred_term: cytokine-mediated signaling pathway
      term:
        id: GO:0019221
        label: cytokine-mediated signaling pathway
    - preferred_term: response to interleukin-4
      term:
        id: GO:0070670
        label: response to interleukin-4
    - preferred_term: response to interleukin-13
      term:
        id: GO:0035962
        label: response to interleukin-13
    gene_products:
    - preferred_term: Interleukin-4
      term:
        id: NCIT:C20508
        label: Interleukin-4
    - preferred_term: Interleukin-13
      term:
        id: NCIT:C20515
        label: Interleukin-13
    - preferred_term: Interleukin-31
      term:
        id: NCIT:C113837
        label: Interleukin-31
    evidence:
    - reference: PMID:31690388
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods.&#34;
      explanation: AD is explicitly described as inflammatory, motivating systemic inflammation as a shared mechanism.
    - reference: PMID:31690388
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;In acute lesions of AD, the T-helper type 2 cells produce interleukin (IL) 4, IL-13, and IL-31, which may potentiate barrier dysfunction and contribute to pruritus.&#34;
      explanation: AD lesions show Th2 cytokine production, supporting a type 2 immune response mechanism.

association_signals:
- source: LITERATURE
  method: EHR_COHORT_ASSOCIATION
  population: Korean NHIS-NSC 2.0 cohort (2002-2015), adults with AD vs matched controls.
  directionality: A_BEFORE_B
  statistics:
    metrics:
    - metric_type: HR
      metric_value: 1.44
      metric_ci_lower: 1.27
      metric_ci_upper: 1.63
      notes: Adjusted hazard ratio for incident T2D in adult AD patients.
    evidence:
    - reference: PMID:37595846
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;The risk of T2DM in the adult AD group was significantly higher than in the control group (adjusted hazard ratio 1.44, 95% confidence interval 1.27-1.63, P &lt; 0.001).&#34;
      explanation: Cohort analysis reports higher T2D risk among adults with AD.
- source: LITERATURE
  method: COMPUTATIONAL_INFERENCE
  population: GWAS summary statistics (MR analysis of AD and T2D).
  directionality: A_BEFORE_B
  statistics:
    metrics:
    - metric_type: OR
      metric_value: 1.07
      metric_ci_lower: 1.02
      metric_ci_upper: 1.11
      notes: Mendelian randomization estimate for AD on T2D.
    evidence:
    - reference: PMID:37322504
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: &#34;Genetically predicted AD led to a higher risk of T2D (OR, 1.07; 95% CI, 1.02, 1.11; P = 0.003).&#34;
      explanation: MR suggests a causal AD -&gt; T2D effect.
- source: LITERATURE
  method: LITERATURE_ASSOCIATION
  population: Systematic review and meta-analysis in adults with AD.
  directionality: UNKNOWN
  statistics:
    metrics:
    - metric_type: OR
      metric_value: 1.11
      metric_ci_lower: 0.87
      metric_ci_upper: 1.42
      notes: Pooled OR for unspecified but suspected T2D; not significant.
    evidence:
    - reference: PMID:29210061
      supports: REFUTE
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;No association was observed between AD and unspecified but suspected type 2 diabetes [pooled odds ratio (OR) 1·11, 95% confidence interval (CI) 0·87-1·42].&#34;
      explanation: Meta-analysis reports no association for unspecified/suspected T2D definitions.
- source: LITERATURE
  method: LITERATURE_ASSOCIATION
  population: Systematic review and meta-analysis in adults with AD (explicitly defined T2D).
  directionality: UNKNOWN
  statistics:
    metrics:
    - metric_type: OR
      metric_value: 1.37
      metric_ci_lower: 1.17
      metric_ci_upper: 1.61
      notes: Pooled OR when T2D is explicitly defined.
    evidence:
    - reference: PMID:29210061
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: &#34;However, AD was associated with type 2 diabetes when explicitly defined, with a pooled OR of 1·37 (95% CI 1·17-1·61).&#34;
      explanation: Meta-analysis reports a positive association for explicitly defined T2D.

phenotypes:
- name: Pruritus
  description: Chronic itch shared across AD and T2D-associated pruritus cohorts.
  phenotype_term:
    preferred_term: Pruritus
    term:
      id: HP:0000989
      label: Pruritus
  evidence:
  - reference: PMID:31690388
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Atopic dermatitis (AD), also known as atopic eczema, is a chronic relapsing inflammatory dermatosis characterized by pruritus, xerosis, and a close association with IgE mediated sensitization to aeroallergens and foods.&#34;
    explanation: AD is explicitly characterized by pruritus.
  - reference: PMID:36852577
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: &#34;Chronic pruritus is an unpleasant sensory perception that negatively affects quality of life and is common among patients with type 2 diabetes mellitus.&#34;
    explanation: Chronic pruritus is reported as common among patients with T2D.
</pre>
            </details>
            
            <div class="field"><span class="field-label">Source:</span><a href="https://github.com/monarch-initiative/dismech/blob/main/kb/comorbidities/com_Atopic_Dermatitis__Type_2_Diabetes_Mellitus.yaml" target="_blank">GitHub</a></div>
            
        </div>
    </div>
</body>
</html>